Skip to main content

Finance & Markets

Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything

Key PointsEli Lilly's breakthroughs in its core therapeutic area are driving excellent financial results.

nasdaq.com ·2h ago

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything fool.com

Read the original at nasdaq.com →

More in Finance & Markets

Nektar Therapeutics options flow shows bullish bets against a bearish tape

2h ago ·investing.com

PagerDuty's 2026 Outlook: Operational Discipline and New AI Opportunities Sustains Profitable Growth Model

This under-the-radar tech stock boasts a Superscore of 72 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

2h ago ·fool.com

Japan consumers boost in-game purchases despite inflation squeeze

2h ago ·asia.nikkei.com

Five Below CMOO Sells 818 Shares at $248.88

Key PointsJacob Kimball Hawkins disposed of 818 shares on September 10, 2026, for a total transaction value of ~$204,000.

2h ago ·nasdaq.com

CVR Energy stock hits 52-week high at 52.41 USD

2h ago ·investing.com

3 Artificial Intelligence (AI) Stocks That Turned $10,000 Into More Than $100,000 in 5 Years (Hint: They've All Outperformed Nvidia)

These stocks are all up more than 900% since September 2021.

2h ago ·fool.com

More from Tuesday 15 September →